These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6186413)

  • 1. 2,6-Dimethyloctanedioic acid--a metabolite of phytanic acid in Refsum's disease.
    Greter J; Lindstedt S; Steen G
    Clin Chem; 1983 Mar; 29(3):434-7. PubMed ID: 6186413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of phytanic acid in Refsum's disease.
    Billimoria JD; Clemens ME; Gibberd FB; Whitelaw MN
    Lancet; 1982 Jan; 1(8265):194-6. PubMed ID: 6172683
    [No Abstract]   [Full Text] [Related]  

  • 3. Occurrence of novel branched-chain fatty acids in Refsum's disease.
    Dulaney JT; Williams M; Evans JE; Costello CE; Kolodny EH
    Biochim Biophys Acta; 1978 Apr; 529(1):1-12. PubMed ID: 76480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refsum's disease and metabolism of phytanic acid.
    Stokke O; Refsum S
    Lancet; 1982 Apr; 1(8277):906-7. PubMed ID: 6175864
    [No Abstract]   [Full Text] [Related]  

  • 5. Infantile Refsum's disease (phytanic acid storage disease): a variant of Zellweger's syndrome?
    Poulos A; Sharp P; Whiting M
    Clin Genet; 1984 Dec; 26(6):579-86. PubMed ID: 6209040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty acid composition of tissues in Refsum's disease (herodopathia atactica polyneuritiformis). Estimation of total phytanic acid accumulation.
    Malmendier CL; Jonniaux G; Voet W; Van Den Bergen CJ
    Biomedicine; 1974 Nov; 20(6):398-407. PubMed ID: 4141904
    [No Abstract]   [Full Text] [Related]  

  • 7. Disorders related to the metabolism of phytanic acid.
    Stokke O; Skjeldal OH; Høie K
    Scand J Clin Lab Invest Suppl; 1986; 184():3-10. PubMed ID: 2438746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phytanic acid alpha-oxidation and complementation analysis of classical Refsum and peroxisomal disorders.
    Poll-The BT; Skjeldal OH; Stokke O; Poulos A; Demaugre F; Saudubray JM
    Hum Genet; 1989 Jan; 81(2):175-81. PubMed ID: 2463966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial oxidation of phytanic acid in human and monkey liver: implication that Refsum's disease is not a peroxisomal disorder.
    Watkins PA; Mihalik SJ
    Biochem Biophys Res Commun; 1990 Mar; 167(2):580-6. PubMed ID: 1690986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence against alpha-hydroxyphytanic acid as an intermediate in the metabolism of phytanic acid.
    Skjeldal OH; Stokke O
    Scand J Clin Lab Invest; 1988 Feb; 48(1):97-102. PubMed ID: 2464193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and biochemical heterogeneity in conditions with phytanic acid accumulation.
    Skjeldal OH; Stokke O; Refsum S; Norseth J; Petit H
    J Neurol Sci; 1987 Jan; 77(1):87-96. PubMed ID: 2433405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phytanic acid oxidase activity in cultured skin fibroblasts. Diagnostic usefulness and limitations.
    Skjeldal OH; Stokke O; Norseth J; Lie SO
    Scand J Clin Lab Invest; 1986 May; 46(3):283-7. PubMed ID: 2424078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infantile phytanic acid storage disease, a possible variant of Refsum's disease: three cases, including ultrastructural studies of the liver.
    Scotto JM; Hadchouel M; Odievre M; Laudat MH; Saudubray JM; Dulac O; Beucler I; Beaune P
    J Inherit Metab Dis; 1982; 5(2):83-90. PubMed ID: 6188882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue distribution of phytanic acid and its analogues in a kinship with Refsum's disease.
    Yao JK; Dyck PJ
    Lipids; 1987 Feb; 22(2):69-75. PubMed ID: 2436023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-Methyladipate excretion in animals fed a phytol supplement with reference to Refsum's disease.
    Krywawych S; Brenton DP; Jackson MJ; Forte C; Walker DK; Lawson AM
    J Inherit Metab Dis; 1985; 8 Suppl 2():147-8. PubMed ID: 2413274
    [No Abstract]   [Full Text] [Related]  

  • 16. 3-Methyladipate excretion in Refsum's disease.
    Brenton DP; Krywawych S
    Lancet; 1982 Mar; 1(8272):624. PubMed ID: 6174838
    [No Abstract]   [Full Text] [Related]  

  • 17. Phytanic acid and very long chain fatty acids in genetic peroxisomal disorders.
    Molzer B; Kainz-Korschinsky M; Sundt-Heller R; Bernheimer H
    J Clin Chem Clin Biochem; 1989 May; 27(5):309-14. PubMed ID: 2474624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisomes, Refsum's disease and the alpha- and omega-oxidation of phytanic acid.
    Wanders RJ; Komen JC
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):865-9. PubMed ID: 17956234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heredopathia atactica polyneurotiformis: therapeutic and pathogenetic aspects.
    Refsum S
    Riv Patol Nerv Ment; 1976 Jun; 97(3):115-26. PubMed ID: 74082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP4 isoform specificity in the omega-hydroxylation of phytanic acid, a potential route to elimination of the causative agent of Refsum's disease.
    Xu F; Ng VY; Kroetz DL; de Montellano PR
    J Pharmacol Exp Ther; 2006 Aug; 318(2):835-9. PubMed ID: 16707724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.